Results 101 to 110 of about 1,827 (136)

The CFII components PCF11 and Cbc change subnuclear localization as cells differentiate in an adult stem cell lineage. [PDF]

MicroPubl Biol
Nava I, Fuller MT, Gallicchio L.
europepmc   +1 more source

Parvovirus RNA Processing: Compact Genomic Organization and Unique Alternative mRNA Processing Mechanisms. [PDF]

Viruses
Uhl LK, Fasina OO.
europepmc   +1 more source

Structural and mechanistic bases for resistance of the M66I capsid variant to lenacapavir. [PDF]

mBio
Briganti L, Annamalai AS, Bester SM, Wei G, Andino-Moncada JR, Singh SP, Kleinpeter AB, Tripathi M, Nguyen B, Radhakrishnan R, Singh PK, Greenwood J, Schope LI, Haney R, Huang S-W, Freed EO, Engelman AN, Francis AC, Kvaratskhelia M.   +18 more
europepmc   +1 more source

In vivo HIV-1 nuclear condensates safeguard against cGAS and license reverse transcription. [PDF]

EMBO J
Ay S, Burlaud-Gaillard J, Gazi A, Tatirovsky Y, Cuche C, Diana JS, Scoca V, Di Santo JP, Roingeard P, Mammano F, Di Nunzio F.   +10 more
europepmc   +1 more source

Crosstalk Between R-Loops, RNA/DNA Modifications, and Cell Death Dynamics in Canine Models of Retinitis Pigmentosa. [PDF]

Invest Ophthalmol Vis Sci
Appelbaum T, Smith DA, Takahashi K, Sudharsan R, Beltran WA.   +4 more
europepmc   +1 more source

<i>CPSF1</i> Is Co-Amplified with <i>MYC</i> but Is Independently Associated with Alternative Polyadenylation in Cancer. [PDF]

Biology (Basel)
Alahmari AA.
europepmc   +1 more source

HIV capsids: orchestrators of innate immune evasion, pathogenesis and pandemicity. [PDF]

J Gen Virol
Morling KL, ElGhazaly M, Milne RSB, Towers GJ.   +3 more
europepmc   +1 more source

The Complex Interactions Between HIV-1 and Human Host Cell Genome: From Molecular Mechanisms to Clinical Practice. [PDF]

Int J Mol Sci
Tolomeo M, Tolomeo F, Cascio A.
europepmc   +1 more source

Cyclophilin A Regulates Tripartite Motif 5 Alpha Restriction of HIV-1. [PDF]

Int J Mol Sci
Wang T, Becker D, Twizerimana AP, Luedde T, Gohlke H, Münk C.   +5 more
europepmc   +1 more source

Combination therapy based on venetoclax overcomes resistance to all-trans retinoic acid and arsenic trioxide in a variant acute promyelocytic leukemia with TNRC18::RARA fusion. [PDF]

Ann Hematol
Ding W, Zhao J, Wang Z, Liu Y, Wang M, Shen H, Chen Y, Huang J, Li D, Chen S, Wen L.   +10 more
europepmc   +1 more source